Literature DB >> 30175690

Compensated right ventricular function of the onset of pulmonary hypertension in a rat model depends on chamber remodeling and contractile augmentation.

Daniela Vélez-Rendón1, Xiaoyan Zhang2, Jesse Gerringer1,3, Daniela Valdez-Jasso1,2.   

Abstract

Right-ventricular function is a good indicator of pulmonary arterial hypertension (PAH) prognosis; however, how the right ventricle (RV) adapts to the pressure overload is not well understood. Here, we aimed at characterizing the time course of RV early remodeling and discriminate the contribution of ventricular geometric remodeling and intrinsic changes in myocardial mechanical properties in a monocrotaline (MCT) animal model. In a longitudinal study of PAH, ventricular morphology and function were assessed weekly during the first four weeks after MCT exposure. Using invasive measurements of RV pressure and volume, heart performance was evaluated at end of systole and diastole to quantify contractility (end-systolic elastance) and chamber stiffness (end-diastolic elastance). To distinguish between morphological and intrinsic mechanisms, a computational model of the RV was developed and used to determine the level of prediction when accounting for wall masses and unloaded volume measurements changes. By four weeks, mean pulmonary arterial pressure and elastance rose significantly. RV pressures rose significantly after the second week accompanied by significant RV hypertrophy, but RV stroke volume and cardiac output were maintained. The model analysis suggested that, after two weeks, this compensation was only possible due to a significant increase in the intrinsic inotropy of RV myocardium. We conclude that this MCT-PAH rat is a model of RV compensation during the first month after treatment, where geometric remodeling on EDPVR and increased myocardial contractility on ESPVR are the major mechanisms by which stroke volume is preserved in the setting of elevated pulmonary arterial pressure. The mediators of this compensation might themselves promote longer-term adverse remodeling and decompensation in this animal model.

Entities:  

Keywords:  effective arterial elastance (Ea); end-diastolic elastance (Eed); end-systolic elastance (Ees); monocrotaline (MCT); sarcomere length-stress

Year:  2018        PMID: 30175690      PMCID: PMC6161210          DOI: 10.1177/2045894018800439

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  35 in total

1.  Numerical evaluation of myofiber orientation and transmural contractile strength on left ventricular function.

Authors:  Xiaoyan Zhang; Premi Haynes; Kenneth S Campbell; Jonathan F Wenk
Journal:  J Biomech Eng       Date:  2015-02-05       Impact factor: 2.097

2.  Cardiac arrhythmia mechanisms in rats with heart failure induced by pulmonary hypertension.

Authors:  David Benoist; Rachel Stones; Mark J Drinkhill; Alan P Benson; Zhaokang Yang; Cecile Cassan; Stephen H Gilbert; David A Saint; Olivier Cazorla; Derek S Steele; Olivier Bernus; Ed White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

Review 3.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

4.  Isoflurane and primary pulmonary hypertension.

Authors:  D C Cheng; G Edelist
Journal:  Anaesthesia       Date:  1988-01       Impact factor: 6.955

5.  Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.

Authors:  David Benoist; Rachel Stones; Mark Drinkhill; Olivier Bernus; Ed White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-11       Impact factor: 4.733

Review 6.  Methods for measuring right ventricular function and hemodynamic coupling with the pulmonary vasculature.

Authors:  Alessandro Bellofiore; Naomi C Chesler
Journal:  Ann Biomed Eng       Date:  2013-02-20       Impact factor: 3.934

7.  Reduction in left ventricular wall stress and improvement in function in failing hearts using Algisyl-LVR.

Authors:  Lik Chuan Lee; Zhang Zhihong; Andrew Hinson; Julius M Guccione
Journal:  J Vis Exp       Date:  2013-04-08       Impact factor: 1.355

8.  Superiority of desflurane over sevoflurane and isoflurane in the presence of pressure-overload right ventricle hypertrophy in rats.

Authors:  Grégoire Blaudszun; Denis R Morel
Journal:  Anesthesiology       Date:  2012-11       Impact factor: 7.892

9.  RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension.

Authors:  Rebecca R Vanderpool; Michael R Pinsky; Robert Naeije; Christopher Deible; Vijaya Kosaraju; Cheryl Bunner; Michael A Mathier; Joan Lacomis; Hunter C Champion; Marc A Simon
Journal:  Heart       Date:  2014-09-11       Impact factor: 5.994

10.  Progressive right ventricular functional and structural changes in a mouse model of pulmonary arterial hypertension.

Authors:  Zhijie Wang; David A Schreier; Timothy A Hacker; Naomi C Chesler
Journal:  Physiol Rep       Date:  2013-12-15
View more
  5 in total

1.  Distinct time courses and mechanics of right ventricular hypertrophy and diastolic stiffening in a male rat model of pulmonary arterial hypertension.

Authors:  Ethan D Kwan; Daniela Vélez-Rendón; Xiaoyan Zhang; Hao Mu; Megh Patel; Erica Pursell; Jennifer Stowe; Daniela Valdez-Jasso
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-08-27       Impact factor: 5.125

2.  Interactions between structural remodeling and volumetric growth in right ventricle in response to pulmonary arterial hypertension.

Authors:  Reza Avazmohammadi; Emilio Mendiola; David Li; Peter Vanderslice; Richard Dixon; Michael Sacks
Journal:  J Biomech Eng       Date:  2019-07-01       Impact factor: 2.097

Review 3.  Computational models of ventricular mechanics and adaptation in response to right-ventricular pressure overload.

Authors:  Oscar O Odeigah; Daniela Valdez-Jasso; Samuel T Wall; Joakim Sundnes
Journal:  Front Physiol       Date:  2022-08-24       Impact factor: 4.755

4.  Effects of the peripheral CB1 receptor antagonist JD5037 in mono- and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension.

Authors:  Patryk Remiszewski; Anna Pędzińska-Betiuk; Krzysztof Mińczuk; Eberhard Schlicker; Justyna Klimek; Janusz Dzięcioł; Barbara Malinowska
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

5.  Multiscale Modeling Framework of Ventricular-Arterial Bi-directional Interactions in the Cardiopulmonary Circulation.

Authors:  Sheikh Mohammad Shavik; Christopher Tossas-Betancourt; C Alberto Figueroa; Seungik Baek; Lik Chuan Lee
Journal:  Front Physiol       Date:  2020-01-31       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.